News

Did Eli Lilly Just Say Checkmate to Novo Nordisk?
Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world ...
Zacks.com on MSN14h
Strength Seen in Lilly (LLY): Can Its 14.3% Jump Turn into More Strength?
Lilly (LLY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
Eli Lilly's Mounjaro Launch In India Ignites Wave Of Weight-Loss Enquiries
The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...
Three more states confirm measles cases
Three more states confirmed their first measles cases of the year over the weekend, as the United States battles a growing ...
Zacks Investment Research on MSN13h
LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study
Shares of Eli Lilly LLY soared 14.3% on April 17 after data from a late-stage study showed that orforglipron achieved the ...
11 Cheap NASDAQ Stocks to Buy According to Hedge Funds
Dan Ives, Head of Global Tech Research at Wedbush Securities, appeared on an interview at CNBC and expressed that the tech ...
El Mundo on MSN15h
The 'Ozempic Effect', this is the silent revolution of the world economy
GLP-1 antidiabetic drugs, which reduce body mass by 25%, impact the processed food or alcohol industry and force fashion and insurance to transform. The unwanted side effect in medicine is any ...
Central Illinois Proud on MSN6h
Can you have a stroke without realizing?
Also called undetected strokes, silent strokes are more common among older individuals, according to the American Health ...
The Indian Express15h
New daily pill can replace injectable weight-loss drugs, show early results
US pharmaceutical giant Eli Lilly has brought out a new experimental pill called Orforglipron, which works consistently to lower weight and blood sugar in a trial of diabetes patients. It reduced ...